13 results
8-K
EX-10.1
COYA
Coya Therapeutics Inc
20 May 24
Coya Therapeutics Announces $5 Million Strategic
5:00pm
not have a Material Adverse Effect. There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit
8-K
EX-10.1
COYA
Coya Therapeutics Inc
6 Dec 23
Entry into a Material Definitive Agreement
7:30am
not have a Material Adverse Effect. There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration
424B4
COYA
Coya Therapeutics Inc
12 May 23
Prospectus supplement with pricing info
4:16pm
litigation against the company that issued the security. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending … the lawsuit. Such a lawsuit could also divert the time and attention of our management.
If securities or industry analysts do not publish research
POS AM
COYA
Coya Therapeutics Inc
8 May 23
Prospectus update (post-effective amendment)
9:00am
a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management
10-K
w7hdy7h llsm9eyw
29 Mar 23
Annual report
4:08pm
424B4
qt6eimsp2x4cx
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
npb0smalifve4f c9cm
5 Dec 22
IPO registration (amended)
8:16am
S-1
l8sm nieexg2
18 Nov 22
IPO registration
5:06pm
DRS/A
oxfgw8x 3i
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
fufkg2
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
qf8lajhkqm3lyr
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next